[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351145-105":59,"doc-detail-351145-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","genetically-shared-signatures-between-covid-19-and-cancer-identified-through-in-silico-case-control-analysis","Genetically Shared Signatures Between COVID-19 and Cancer Identified Through In Silico Case-Control Analysis","","Cancer patients show heightened vulnerability to infections because malignancy and treatment can induce immunosuppression. The COVID-19 pandemic exposed this risk, yet the molecular links between cancer progression and COVID-19 severity remain unclear. This study used integrative in silico case–control analysis of GEO transcriptomic datasets to compare mild and severe COVID-19 across TNBC, breast cancer, and ccRCC, identifying shared genes, regulatory networks, and enriched pathways tied to inflammation, immune regulation, and tumor progression.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genetically-shared-signatures-between-covid-19-and-cancer-identified-through-in-silico-case-control-analysis/351145/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genetically-shared-signatures-between-covid-19-and-cancer-identified-through-in-silico-case-control-analysis/351145.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main objective?","Question",{"text":112,"@type":113},"To identify shared molecular signatures between COVID-19 and cancers including TNBC, breast cancer, and clear cell renal cell carcinoma using integrative bioinformatics approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What datasets and analytical strategy were used?",{"text":117,"@type":113},"The analysis used publicly available GEO transcriptomic datasets (GSE164805, GSE139038, GSE45498, and GSE105261) and compared mild versus severe COVID-19 cases with each cancer type.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biological findings were highlighted in the results?",{"text":121,"@type":113},"Shared hub genes across COVID-19 and cancer datasets and convergent enriched pathways (e.g., MAPK signaling and cytokine–cytokine receptor interaction) were identified, along with regulatory molecules affecting both viral and oncogenic processes.",{"name":123,"@type":110,"acceptedAnswer":124},"How does the study interpret the relationship between severe COVID-19 and aggressive cancers?",{"text":125,"@type":113},"It reports persistent immune activation and altered immune communication as common underlying themes linking severe COVID-19 with aggressive cancers, without implying causality or specific clinical outcome effects.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},351145,1790520976,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Article  \nGenetically Shared Signatures Between COVID-19 and Cancer Identified Through In Silico Case–Control Analysis  \nAmmar Yasir Ahmed Ahmed 1 and Sevinç Akçay 2, *  \nAcademic Editor: Xin Wang  \nReceived: 13 January 2026  \nRevised: 23 January 2026  \nAccepted: 27 January 2026  \nPublished: 28 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 College of Pharmacy, University of Al Maarif, Al Anbar P.O. Box 55431, Iraq; [ammar.yasir@uao.edu.iq](ammar.yasir@uao.edu.iq)  \n2 Department of Molecular Biology and Genetics, Faculty of Science and Arts, Kır¸sehir Ahi Evran University, Kır¸sehir 40100, Türkiye  \n* Correspondence: [sevinc.akcay@ahievran.edu.tr](sevinc.akcay@ahievran.edu.tr); Tel.: +90-5538804041  \nAbstract  \nBackground/Objectives: Cancer patients are highly susceptible to infectious diseases due to malignancy-and treatment-induced immunosuppression. The coronavirus disease 2019 (COVID-19) pandemic highlighted this vulnerability, particularly in aggressive tumors such as triple-negative breast cancer (TNBC) and clear cell renal cell carcinoma (ccRCC) . However, the molecular mechanisms linking cancer progression with COVID-19 severity remain poorly defined. This study aimed to identify shared molecular signatures between COVID-19 and TNBC, breast cancer, and ccRCC using integrative bioinformatics approaches. Methods: A comprehensive in silico case–control analysis was conducted using publicly available GEO transcriptomic datasets (GSE164805, GSE139038, GSE45498, and GSE105261) . Differentially expressed genes (DEGs) were identified by comparing mild and severe COVID-19 cases with each cancer type. Protein–protein interaction (PPI) networks were constructed to identify hub genes, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Regulatory networks involving microRNAs (miRNAs) and transcription factors (TFs) were also examined. Results: Shared hub genes were identified across COVID-19 and cancer datasets, including IGF1, MMP9, and NOTCH1 in TNBC; TOP2A, PXN, and CCNB1 in breast cancer; and ASPM and TTK in ccRCC. These genes are linked to immune regulation, inflammation, cell cycle control, and tumor progression. Enrichment analyses revealed convergent pathways such as MAPK signaling, cytokine–cytokine receptor interaction, Ras signaling, and proteoglycans in cancer. Key regulatory molecules, including miR-145-5p, miR-192-5p, miR-335-5p, and transcription factors NFKB1, BRCA1, and TP53, modulated both viral and oncogenic processes. Severe COVID-19 was associated with enhanced inflammatory and proliferation-related signaling across all cancer types. Conclusions: This integrative, severity-stratified analysis identifies shared molecular and regulatory features linking severe COVID-19 with aggressive cancers, highlighting persistent immune activation and altered immune communication as common underlying themes without implying causality or clinical outcome effects. These findings provide a systems-level, hypothesis-generating framework for understanding virus–cancer interactions and may inform future biomarker discovery and immune-focused therapeutic strategies in vulnerable cancer populations.  \nKeywords: cancer patients; breast cancer; clear cell renal cell carcinoma; triple-negative breast cancer; differentially expressed genes  \n1. Introduction  \nThe coronavirus disease 2019 (COVID-19) pandemic has become a global public health challenge since its emergence in late 2019 [1] . The causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been responsible for widespread morbidity and mortality worldwide [2] . Among the most vulnerable populations are individuals with cancer, who often experience more severe outcomes due to weakened immune systems resulting from the disea","cbCaieg7r3FdAw2Z","https://ap.wps.com/l/cbCaieg7r3FdAw2Z","pdf",3653854,21,"English","# Abstract\n## Background/Objectives\n## Methods\n## Results\n## Conclusions\n# 1. Introduction","[{\"question\":\"What was the study’s main objective?\",\"answer\":\"To identify shared molecular signatures between COVID-19 and cancers including TNBC, breast cancer, and clear cell renal cell carcinoma using integrative bioinformatics approaches.\"},{\"question\":\"What datasets and analytical strategy were used?\",\"answer\":\"The analysis used publicly available GEO transcriptomic datasets (GSE164805, GSE139038, GSE45498, and GSE105261) and compared mild versus severe COVID-19 cases with each cancer type.\"},{\"question\":\"Which biological findings were highlighted in the results?\",\"answer\":\"Shared hub genes across COVID-19 and cancer datasets and convergent enriched pathways (e.g., MAPK signaling and cytokine–cytokine receptor interaction) were identified, along with regulatory molecules affecting both viral and oncogenic processes.\"},{\"question\":\"How does the study interpret the relationship between severe COVID-19 and aggressive cancers?\",\"answer\":\"It reports persistent immune activation and altered immune communication as common underlying themes linking severe COVID-19 with aggressive cancers, without implying causality or specific clinical outcome effects.\"}]","Genetically Shared Signatures Between COVID-19 and Cancer Identified Through In Silico Case-Control Analysis | PDF",1790092814,53,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1351c3513921ab3bd16ac935380bacc4.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3d72a9f822a77db0efd2e9b2318ef04.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b93856647d1733edc8f8e28f253e740.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d863073a28abf563237cc9b118460227.webp",980,1385]